Search

Anna Pagonakis

Examiner (ID: 6985)

Most Active Art Unit
1628
Art Unit(s)
1614, 4173, 1609, 1628, OPET
Total Applications
1238
Issued Applications
444
Pending Applications
73
Abandoned Applications
723

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5515597 [patent_doc_number] => 20090215904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'COLCHICINE COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 12/465210 [patent_app_country] => US [patent_app_date] => 2009-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24204 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215904.pdf [firstpage_image] =>[orig_patent_app_number] => 12465210 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/465210
COLCHICINE COMPOSITIONS AND METHODS May 12, 2009 Abandoned
Array ( [id] => 5484928 [patent_doc_number] => 20090274693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-05 [patent_title] => 'Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/435473 [patent_app_country] => US [patent_app_date] => 2009-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9217 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20090274693.pdf [firstpage_image] =>[orig_patent_app_number] => 12435473 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/435473
Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor May 4, 2009 Abandoned
Array ( [id] => 5315514 [patent_doc_number] => 20090280112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS' [patent_app_type] => utility [patent_app_number] => 12/434071 [patent_app_country] => US [patent_app_date] => 2009-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14026 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280112.pdf [firstpage_image] =>[orig_patent_app_number] => 12434071 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/434071
INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS Apr 30, 2009 Abandoned
Array ( [id] => 5392321 [patent_doc_number] => 20090209634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR DISEASE MODIFICATION / EPILEPTOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/431141 [patent_app_country] => US [patent_app_date] => 2009-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20035 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209634.pdf [firstpage_image] =>[orig_patent_app_number] => 12431141 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/431141
USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR DISEASE MODIFICATION / EPILEPTOGENESIS Apr 27, 2009 Abandoned
Array ( [id] => 6548797 [patent_doc_number] => 20100222401 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIC ANGIOGENESIS AND VASCULAR PERMEABILITY' [patent_app_type] => utility [patent_app_number] => 12/667168 [patent_app_country] => US [patent_app_date] => 2009-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 38581 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222401.pdf [firstpage_image] =>[orig_patent_app_number] => 12667168 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/667168
COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIC ANGIOGENESIS AND VASCULAR PERMEABILITY Apr 15, 2009 Abandoned
Array ( [id] => 5943538 [patent_doc_number] => 20110104158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'DEUTERIUM BEARING ANALOGS OF ANASTROZOLE AS AROMATASE INHIBITORS FOR THE TREATMENT OF BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/937935 [patent_app_country] => US [patent_app_date] => 2009-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7211 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104158.pdf [firstpage_image] =>[orig_patent_app_number] => 12937935 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/937935
DEUTERIUM BEARING ANALOGS OF ANASTROZOLE AS AROMATASE INHIBITORS FOR THE TREATMENT OF BREAST CANCER Apr 14, 2009 Abandoned
Array ( [id] => 9608256 [patent_doc_number] => 08785423 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases' [patent_app_type] => utility [patent_app_number] => 12/937900 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 8725 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937900 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/937900
Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases Apr 13, 2009 Issued
Array ( [id] => 5527836 [patent_doc_number] => 20090197913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'SYNERGISTIC MODULATION OF FLT3 KINASE USING A FLT3 INHIBITOR AND A FARNESYL TRANSFERASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/421778 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 70427 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197913.pdf [firstpage_image] =>[orig_patent_app_number] => 12421778 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421778
Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor Apr 9, 2009 Issued
Array ( [id] => 5527836 [patent_doc_number] => 20090197913 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'SYNERGISTIC MODULATION OF FLT3 KINASE USING A FLT3 INHIBITOR AND A FARNESYL TRANSFERASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/421778 [patent_app_country] => US [patent_app_date] => 2009-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 70427 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197913.pdf [firstpage_image] =>[orig_patent_app_number] => 12421778 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421778
Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor Apr 9, 2009 Issued
Array ( [id] => 5558820 [patent_doc_number] => 20090270397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-29 [patent_title] => 'Methods and compositions for the treatment of cancers, such as melanomas and gliomas' [patent_app_type] => utility [patent_app_number] => 12/384777 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15952 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20090270397.pdf [firstpage_image] =>[orig_patent_app_number] => 12384777 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/384777
Methods and compositions for the treatment of cancers, such as melanomas and gliomas Apr 7, 2009 Abandoned
Array ( [id] => 5458786 [patent_doc_number] => 20090258938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Administration of 6\'-ethyl lepimectin, 6\' -methyl lepimectin or derivatives thereof for treating dermatological disorders in humans' [patent_app_type] => utility [patent_app_number] => 12/382888 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2892 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258938.pdf [firstpage_image] =>[orig_patent_app_number] => 12382888 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/382888
Administration of 6'-ethyl lepimectin, 6' -methyl lepimectin or derivatives thereof for treating dermatological disorders in humans Mar 25, 2009 Abandoned
Array ( [id] => 5496488 [patent_doc_number] => 20090264516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Milbemycin compounds and treatment of dermatological disorders in humans therewith' [patent_app_type] => utility [patent_app_number] => 12/382892 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3147 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20090264516.pdf [firstpage_image] =>[orig_patent_app_number] => 12382892 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/382892
Milbemycin compounds and treatment of dermatological disorders in humans therewith Mar 25, 2009 Abandoned
Array ( [id] => 5316577 [patent_doc_number] => 20090281175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'Avermectin compounds and treatment of dermatological disorders in humans therewith' [patent_app_type] => utility [patent_app_number] => 12/382890 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2989 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20090281175.pdf [firstpage_image] =>[orig_patent_app_number] => 12382890 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/382890
Avermectin compounds and treatment of dermatological disorders in humans therewith Mar 25, 2009 Abandoned
Array ( [id] => 4451323 [patent_doc_number] => 07964647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-21 [patent_title] => 'Colchicine compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/407980 [patent_app_country] => US [patent_app_date] => 2009-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24214 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/964/07964647.pdf [firstpage_image] =>[orig_patent_app_number] => 12407980 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/407980
Colchicine compositions and methods Mar 19, 2009 Issued
Array ( [id] => 5374812 [patent_doc_number] => 20090312373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'METHODS FOR THE TREATMENT OF CANCER USING PIPERLONGUMINE AND PIPERLONGUMINE ANALOGS' [patent_app_type] => utility [patent_app_number] => 12/401099 [patent_app_country] => US [patent_app_date] => 2009-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 20126 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312373.pdf [firstpage_image] =>[orig_patent_app_number] => 12401099 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/401099
METHODS FOR THE TREATMENT OF CANCER USING PIPERLONGUMINE AND PIPERLONGUMINE ANALOGS Mar 9, 2009 Abandoned
Array ( [id] => 5436343 [patent_doc_number] => 20090170930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'METHODS FOR DIRECTING DIFFERENTIATION OF CLONOGENIC NEURAL STEM CELLS WITH COUMARINS' [patent_app_type] => utility [patent_app_number] => 12/400756 [patent_app_country] => US [patent_app_date] => 2009-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3421 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170930.pdf [firstpage_image] =>[orig_patent_app_number] => 12400756 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/400756
METHODS FOR DIRECTING DIFFERENTIATION OF CLONOGENIC NEURAL STEM CELLS WITH COUMARINS Mar 8, 2009 Abandoned
Array ( [id] => 6159513 [patent_doc_number] => 20110158983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES' [patent_app_type] => utility [patent_app_number] => 12/921145 [patent_app_country] => US [patent_app_date] => 2009-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57903 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20110158983.pdf [firstpage_image] =>[orig_patent_app_number] => 12921145 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/921145
COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES Mar 4, 2009 Abandoned
Array ( [id] => 6228822 [patent_doc_number] => 20100183560 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Angiogenesis-modulating compositions and uses' [patent_app_type] => utility [patent_app_number] => 12/380583 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 48881 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183560.pdf [firstpage_image] =>[orig_patent_app_number] => 12380583 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/380583
Angiogenesis-modulating compositions and uses Feb 26, 2009 Abandoned
Array ( [id] => 5369020 [patent_doc_number] => 20090306579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS' [patent_app_type] => utility [patent_app_number] => 12/391836 [patent_app_country] => US [patent_app_date] => 2009-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9304 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306579.pdf [firstpage_image] =>[orig_patent_app_number] => 12391836 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/391836
DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS Feb 23, 2009 Abandoned
Array ( [id] => 6531788 [patent_doc_number] => 20100221307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'ANTIVIRAL AGENTS, ANTIVIRAL FIBERS AND ANTIVIRAL FIBER STRUCTURES' [patent_app_type] => utility [patent_app_number] => 12/733795 [patent_app_country] => US [patent_app_date] => 2009-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10377 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221307.pdf [firstpage_image] =>[orig_patent_app_number] => 12733795 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/733795
ANTIVIRAL AGENTS, ANTIVIRAL FIBERS AND ANTIVIRAL FIBER STRUCTURES Feb 19, 2009 Abandoned
Menu